1-苯磺基-1H-吡咯并[2,3-B]吡啶-3-甲酸甲基酯 | 245064-81-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 1-苯磺基-1H-吡咯并[2,3-B]吡啶-3-甲酸甲基酯
• 中文别名: 1-苯磺基-1H-吡咯并[2,3-b]吡啶-3-甲酸甲基酯
• 英文名称: 1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine-3-carboxylic acid methyl ester
• 英文别名: Methyl 1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine-3-carboxylate；methyl 1-(benzenesulfonyl)pyrrolo[2,3-b]pyridine-3-carboxylate
• CAS: 245064-81-7
• 化学式: C₁₅H₁₂N₂O₄S
• 分子量: 316.337
• InChiKey: PRKMFYZEFIQCKV-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  22
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  86.6
• 氢给体数：
  0
• 氢受体数：
  5

安全信息

• 海关编码：
  2933990090

反应信息

• 作为反应物：
  描述：

  1-苯磺基-1H-吡咯并[2,3-B]吡啶-3-甲酸甲基酯 在 sodium t-butanolate 作用下， 以 1,4-二氧六环 为溶剂， 反应 3.0h， 以66%的产率得到1H-吡咯并[2,3-B]吡啶-3-羧酸甲酯
  参考文献：
  名称：

  Desulfonylation of Indoles and 7-Azaindoles Using Sodium tert-Butoxide

  摘要：

  本文介绍了一种温和的 N-吲哚和 N-氮杂吲哚脱磺化方法。脱保护是在二噁烷中使用叔丁醇钠在碱性条件下进行的。这种方法非常温和，可用于对包括已知对酸性或碱性条件敏感的功能在内的化合物进行脱保护。

  DOI：

  10.1055/s-0029-1219918
• 作为产物：
  描述：

  7-氮杂吲哚-3-甲醛 在 盐酸 、 sodium chlorite 、 氨基磺酸 、 sodium hydride 作用下， 以 四氢呋喃 、 1,4-二氧六环 、 水 为溶剂， 反应 0.5h， 生成 1-苯磺基-1H-吡咯并[2,3-B]吡啶-3-甲酸甲基酯
  参考文献：
  名称：

  Synthesis of benzo[5′,6′]cyclohepta[4,5]pyrrolo[2,3-b]pyridin-12-one

  摘要：

  The synthesis of a 7-azaindole derivative 8 with potential antitumoral activity is described starting from pyrrolo[2,3-b]pyridine; regioselective lithiation/methylation of alkyl 7-azaindole-3-carboxylates 4 afforded the 2-methyl derivatives 5. Demethylation of eater 6a using BBr3 afforded the acid 7, which is cyclised into the tetracyclic derivative 8. (C) 1999 Published by Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0040-4039(99)01138-7

文献信息

• [EN] PYRROLO[2,3-b] PYRIDINE DERIVATIVES ACTIVE AS KINASE INHIBITORS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION COMPRISING THEM<br/>[FR] DERIVES PYRROLO[2,3-B]PYRIDINE AGISSANT COMME INHIBITEURS DES KINASES, PROCEDE POUR LEUR ELABORATION, ET COMPOSITIONS PHARMACEUTIQUES LES COMPRENANT
  申请人：PHARMACIA ITALIA SPA

  公开号：WO2005063747A1

  公开（公告）日：2005-07-14

  Compounds which are pyrrolo[2,3-b]pyridine derivatives or pharmaceutically acceptable salts thereof, their preparation process and pharmaceutical compositions comprising them are disclosed; these compounds are useful in the treatment of diseases caused by and/or associated with an altered protein kinase activity such as cancer, cell proliferative disorders, Alzheimer's disease, viral infections, auto-immune diseases and neurodegenrative disorders; also disclosed is a process under SPS conditions for preparing the compounds of the invention and chemical libraries comprising a plurality of them.

  本发明揭示了属于吡咯并[2,3-b]吡啶衍生物或其药用可接受盐的化合物，以及它们的制备过程和包含它们的药物组合物；这些化合物对治疗由蛋白激酶活性改变引起和/或相关的疾病具有用处，如癌症、细胞增殖异常、阿尔茨海默病、病毒感染、自身免疫疾病和神经退行性疾病；还揭示了一种在SPS条件下制备本发明化合物的方法，以及包含多种这些化合物的化学文库。
• [EN] PYRROLO[2,3-b]PYRIDINE DERIVATIVES ACTIVE AS KINASE INHIBITORS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM<br/>[FR] DERIVES PYRROLO[2,3-B]PYRIDINE AGISSANT COMME INHIBITEURS DES KINASES, PROCEDE POUR LEUR ELABORATION, ET COMPOSITIONS PHARMACEUTIQUES LES COMPRENANT
  申请人：PHARMACIA ITALIA SPA

  公开号：WO2005063746A1

  公开（公告）日：2005-07-14

  Compounds which are pyrrolo[2,3-b]pyridine derivatives or pharmaceutically acceptable salts thereof, their preparation process and pharmaceutical compositions comprising them are disclosed; these compounds are useful in the treatment of diseases caused by and/or associated with an altered protein kinase activity such as cancer, cell proliferative disorders, Alzheimer's disease, viral infections, auto-immune diseases and neurodegenerative disorders; also disclosed is a process under SPS conditions for preparing the compounds of the invention and chemical libraries comprising a plurality of them.

  本发明揭示了一种吡咯并[2,3-b]吡啶衍生物或其药学上可接受的盐，其制备过程和包含它们的制药组合物；这些化合物在治疗由改变的蛋白激酶活性引起和/或与之相关的疾病方面具有用处，例如癌症、细胞增殖性疾病、阿尔茨海默病、病毒感染、自身免疫性疾病和神经退行性疾病；本发明还揭示了一种在SPS条件下制备本发明化合物的方法和包含多种化合物的化学文库。
• Pyrrolo[2,3-b]pyridine derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
  申请人：Salom Barbara

  公开号：US20050256151A1

  公开（公告）日：2005-11-17

  Compounds which are pyrrolo[2,3-b]pyridine derivatives or pharmaceutically acceptable salts thereof, their preparation process and pharmaceutical compositions comprising them are disclosed; these compounds are useful in the treatment of diseases caused by and/or associated with an altered protein kinase activity such as cancer, cell proliferative disorders, Alzheimer's disease, viral infections, auto-immune diseases and neurodegenerative disorders; also disclosed is a process under SPS conditions for preparing the compounds of the invention and chemical libraries comprising a plurality of them.

  本发明公开了一种吡咯并[2,3-b]吡啶衍生物或其药学上可接受的盐，以及它们的制备方法和包含它们的药物组合物；这些化合物对治疗由改变蛋白激酶活性引起和/或与之相关的疾病如癌症、细胞增殖性疾病、阿尔茨海默病、病毒感染、自身免疫疾病和神经退行性疾病非常有用；本发明还公开了一种在SPS条件下制备本发明化合物和包含多种化合物的化学库的方法。
• PYRROLE[2,3-B]PYRIDINE DERIVATIVES ACTIVE AS KINASE INHIBITORS
  申请人：Salom Barbara

  公开号：US20110136857A1

  公开（公告）日：2011-06-09

  Compounds which are pyrrolo[2,3-b]pyridine derivatives or pharmaceutically acceptable salts thereof, their preparation process and pharmaceutical compositions comprising them are disclosed; these compounds are useful in the treatment of diseases caused by and/or associated with an altered protein kinase activity such as cancer, cell proliferative disorders, Alzheimer's disease, viral infections, auto-immune diseases and neurodegenerative disorders; also disclosed is a process under SPS conditions for preparing the compounds of the invention and chemical libraries comprising a plurality of them.

  本发明公开了吡咯并[2,3-b]吡啶衍生物化合物或其药学上可接受的盐、其制备方法以及包含它们的制药组合物；这些化合物可用于治疗由改变的蛋白激酶活性引起和/或相关的疾病，如癌症、细胞增殖性疾病、阿尔茨海默病、病毒感染、自身免疫疾病和神经退行性疾病；本发明还公开了一种在SPS条件下制备本发明化合物以及包含多种化合物的化学文库的方法。
• PYRROLO[2,3-b] PYRIDINE DERIVATIVES ACTIVE AS KINASE INHIBITORS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION COMPRISING THEM
  申请人：Pfizer Italia S.r.l.

  公开号：EP1704147A1

  公开（公告）日：2006-09-27